Skip to main content
Wiley - PMC COVID-19 Collection logoLink to Wiley - PMC COVID-19 Collection
letter
. 2020 Jul 10;28(8):1370. doi: 10.1002/oby.22877

COVID‐19 Ventilatory Phenotypes and Obesity: Is There a Relationship?

Hugo Costa 1,2,, Miguel Jacob 2,3, Rafaela Pereira 2,4, Roberto Calças 2,5, Daniel Nuñez 6
PMCID: PMC7273047  PMID: 32384227

To the Editor: Obesity has been recognized as an independent risk factor in other viral infections such as influenza A virus subtype H1N1 (1). Although data are scarce at this stage, there is also an unexplained increased prevalence of obesity in patients infected with SARS‐CoV‐2 (severe acute respiratory syndrome coronavirus 2) admitted to the intensive care units (2).

In SARS‐CoV‐2 pneumonia, two different ventilatory phenotypes have been described (3). The L phenotype (Low) presents with low elastance and high compliance, low ventilation/perfusion ratio, and decreased recruitability; in this case, the factor limiting pulmonary function will be perfusion. Moreover, the H phenotype (High) presents with high elastance and low compliance, pulmonary shunts, and high recruitability; the factor limiting pulmonary function will be ventilation (3).

In our intensive care unit, we have observed an unexplained increased prevalence of patients with obesity and SARS‐CoV‐2 pneumonia with ventilatory phenotype H (acute respiratory distress syndrome–like). From the ventilatory point of view, the patients need high positive end‐expiratory pressure and respond well to recruitment maneuvers.

The incidence of acute respiratory distress syndrome is increased in patients with obesity (4). To date, there are no studies that mention the association between the ventilatory phenotypes of COVID‐19 and obesity. We suggest that understanding these relationships is crucial and clinically important in the treatment of patients with obesity and COVID‐19 pulmonary complications. We urge authors to report ventilatory phenotypes in their studies of patients with obesity and pulmonary complications of COVID‐19.

Disclosure

The authors declared no conflict of interest.

Contributor Information

Hugo Costa, Email: hugoalexcosta@sapo.pt.

Daniel Nuñez, Email: quicodaneil@hotmail.com.

References

  • 1. Kerkhove V, Vandemaele KA, Shinde V, et al. Risk factors for severe outcomes following 2009 influenza A (H1N1) infection: a global pooled analysis. PLoS Med 2011;8:e1001053. doi:10.1371/journal.pmed.1001053 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2. Simonnet A, Chetboun M, Poissy J, et al. High prevalence of obesity in SARS‐CoV‐2 requiring invasive mechanical ventilation. Obesity (Silver Spring) 2020;28:1195‐1199. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. Gattinoni L, Chiumello D, Caironi P, et al. COVID‐19 pneumonia: different respiratory treatments for different phenotypes? Intensive Care Med 2020;46:1099‐1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 4. Gong MN, Bajwa EK, Thompson BT, Christiani DC. Body mass index is associated with the development of acute respiratory distress syndrome. Thorax 2010;65:44‐50. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from Obesity (Silver Spring, Md.) are provided here courtesy of Wiley

RESOURCES